Literature DB >> 3202828

Kinetic lability of zinc bound to metallothionein in Ehrlich cells.

S K Krezoski1, J Villalobos, C F Shaw, D H Petering.   

Abstract

Ehrlich ascites-tumour cells normally contain a large concentration of Zn-metallothionein. When cells are placed in culture media, containing or pretreated with the metal-ion-chelating resin Chelex-100, they stop growing, remain viable and lose zinc specifically from the metallothionein (MT) pool. The kinetics of loss of zinc are first-order and are very rapid, having a rate constant of greater than or equal to 0.6 h-1. MT protein labelled with 35S is biodegraded with a rate constant of 0.07-0.014 h-1 in control cells, 0.08 h-1 in cells exposed to the zinc-deficient medium and 0.12-0.18 h-1 in cells treated directly with Chelex. Over the 6 h period in which zinc is totally lost from Zn-MT there is relatively little decrease in MT-like protein as measured by cadmium-binding to the 10,000-Mr protein fraction. Other pools of zinc and 35S-labelled protein turn over more slowly. There is no loss of zinc from rat liver Zn-MT that is dialysed against Chelex to model the possible reaction of the resin with Ehrlich-cell Zn-MT. However, Chelex does compete slowly for MT-bound zinc when resin and MT are directly mixed. Analysis of the known and possible pathways of zinc metabolism in cells in relationship to these rate constants shows that biodegradation of MT protein cannot account for the rate of loss of zinc from Zn-MT.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202828      PMCID: PMC1135254     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Metallothionein: a cadmium and zinc-containign protein from equine renal cortex. II. Physico-chemical properties.

Authors:  J H KAGI; B L VALLEE
Journal:  J Biol Chem       Date:  1961-09       Impact factor: 5.157

2.  Degradation of hepatic zinc-thionein after parenteral zinc administration.

Authors:  S L Feldman; R J Cousins
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

3.  Zinc-binding protein in the livers of neonatal, normal and partially hepatectomized rats.

Authors:  H Ohtake; K Hasegawa; M Koga
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

4.  Zinc-, copper- and cadmium-binding protein in Ehrlich ascites tumour cells.

Authors:  J Koch; S Wielgus; B Shankara; L A Saryan; C F Shaw; D H Petering
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

5.  Biological function of metallothionein-IV. Biosynthesis and degradation of liver and kidney metallothionein in rats fed diets containing zinc or cadmium.

Authors:  S H Oh; J T Deagen; P D Whanger; P H Weswig
Journal:  Bioinorg Chem       Date:  1978

6.  Zinc deficiency and growth of Ehrlich ascites tumor.

Authors:  D T Minkel; P J Dolhun; B L Calhoun; L A Saryan; D H Petering
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

7.  Effects of ethylenediaminetetraacetic acid and 1,10-phenanthroline on cell proliferation and DNA synthesis of Ehrlich ascites cells.

Authors:  C Krishnamurti; L A Saryan; D H Petering
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

8.  Ligand substitution reactions of metallothioneins with EDTA and apo-carbonic anhydrase.

Authors:  T Y Li; A J Kraker; C F Shaw; D H Petering
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

9.  Reactivation in vitro of zinc-requiring apo-enzymes by rat liver zinc-thionein.

Authors:  A O Udom; F O Brady
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

10.  Comparative cytotoxic and biochemical effects of ligands and metal complexes of alpha-N-heterocyclic carboxaldehyde thiosemicarbazones.

Authors:  L A Saryan; E Ankel; C Krishnamurti; D H Petering; H Elford
Journal:  J Med Chem       Date:  1979-10       Impact factor: 7.446

View more
  15 in total

1.  Cell cycle regulation of metallothionein in human colonic cancer cells.

Authors:  W W Nagel; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

Review 2.  Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy.

Authors:  Mohammad Namdarghanbari; William Wobig; Susan Krezoski; Niloofar M Tabatabai; David H Petering
Journal:  J Biol Inorg Chem       Date:  2011-08-07       Impact factor: 3.358

3.  Selenium redox biochemistry of zinc-sulfur coordination sites in proteins and enzymes.

Authors:  C Jacob; W Maret; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Differential fluorescence labeling of cysteinyl clusters uncovers high tissue levels of thionein.

Authors:  Y Yang; W Maret; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

5.  The Delta33-35 Mutant alpha-Domain Containing beta-Domain-Like M(3)S(9) Cluster Exhibits the Function of alpha-Domain with M(4)S(11) Cluster in Human Growth Inhibitory Factor.

Authors:  Qingui Bao; Zhichun Ding; Zhong-Xian Huang; Xiangshi Tan
Journal:  Bioinorg Chem Appl       Date:  2010-05-17       Impact factor: 7.778

6.  Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange.

Authors:  W Maret
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

7.  A putative glutathione-binding site in CdZn-metallothionein identified by equilibrium binding and molecular-modelling studies.

Authors:  M Brouwer; T Hoexum-Brouwer; R E Cashon
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

8.  The ATP-metallothionein complex.

Authors:  L J Jiang; W Maret; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  A mutant mouse (tx) with increased hepatic metallothionein stability and accumulation.

Authors:  J Koropatnick; M G Cherian
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

10.  Zinc binding ligands and cellular zinc trafficking: apo-metallothionein, glutathione, TPEN, proteomic zinc, and Zn-Sp1.

Authors:  Ujala Rana; Rajendra Kothinti; Jeffrey Meeusen; Niloofar M Tabatabai; Susan Krezoski; David H Petering
Journal:  J Inorg Biochem       Date:  2007-11-28       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.